Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. Approximately 80% of patients initially diagnosed with locally advanced or metastatic disease survive only 4–11 months after diagnosis. Tremendous efforts have been made toward understanding the biology of PDAC. RESULTS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hongjin, Tian, Weiwei, Tai, Xiang, Li, Xuanpeng, Li, Ziwei, Shui, Jing, Yu, Juehua, Wang, Zhihua, Zhu, Xiaosong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600871/
https://www.ncbi.nlm.nih.gov/pubmed/34789165
http://dx.doi.org/10.1186/s12864-021-08137-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600871/
https://www.ncbi.nlm.nih.gov/pubmed/34789165
http://dx.doi.org/10.1186/s12864-021-08137-5

Ejemplares similares